We are live on ! Find out more
PFCS

Pale Fire Capital SE Portfolio holdings

AUM $1.14B
1-Year Est. Return 42.87%
This Fund
S&P 500
This Quarter Est. Return
-11.94%
1 Year Est. Return
+42.87%
3 Year Est. Return
+176.09%
5 Year Est. Return
10 Year Est. Return
AUM
$1.14B
AUM Growth
-$352M
Cap. Flow
-$182M
Cap. Flow %
-16.03%
Top 10 Hldgs %
84.57%
Holding
81
New
21
Increased
23
Reduced
8
Closed
21

Top Buys

Rank Stock Value
1
BTG icon
B2Gold
BTG
+$153M
2
PHR icon
Phreesia
PHR
+$114M
3
COUR icon
Coursera
COUR
+$65.6M
4
ZD icon
Ziff Davis
ZD
+$57.9M
5
LSPD icon
Lightspeed Commerce
LSPD
+$55.2M

Sector Composition

Rank Sector Weight
1 Materials 31.42%
2 Communication Services 26.38%
3 Consumer Staples 17.74%
4 Healthcare 16.56%
5 Technology 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLMD icon
51
Relmada Therapeutics
RLMD
$544M
$220K 0.02%
31,650
-12,900
-29% -$61K
GPRK icon
52
GeoPark
GPRK
$649M
$204K 0.02%
+21,500
New +$181K
CGEM icon
53
Cullinan Oncology
CGEM
$1.05B
$202K 0.02%
14,218
-5,100
-26% -$65.5K
CRBP icon
54
Corbus Pharmaceuticals
CRBP
$170M
$200K 0.02%
21,350
+2,700
+14% +$22.7K
FULC icon
55
Fulcrum Therapeutics
FULC
$248M
$200K 0.02%
+26,100
New +$242K
PALI icon
56
Palisade Bio
PALI
$339M
$195K 0.02%
111,410
+40,700
+58% +$74K
NPB
57
Northpointe Bancshares
NPB
$594M
$177K 0.02%
+10,258
New +$181K
GRCE
58
Grace Therapeutics
GRCE
$37.9M
$175K 0.02%
+37,762
New +$148K
ENGN icon
59
enGene Therapeutics
ENGN
$122M
$163K 0.01%
24,004
IMTX icon
60
Immatics
IMTX
$1.24B
$160K 0.01%
16,272
AGRO icon
61
Adecoagro
AGRO
$1.53B
-84,637
Closed -$671K
ANNX icon
62
Annexon
ANNX
$855M
-38,600
Closed -$194K
ATAI icon
63
AtaiBeckley Inc
ATAI
$2.66B
-45,811
Closed -$187K
CGAU
64
Centerra Gold
CGAU
$3.22B
-591,222
Closed -$8.5M
COIN icon
65
PUT
Coinbase
COIN
$41.7B
-1,271,800
Closed -$288M
CRTO icon
66
Criteo
CRTO
$1.03B
-18,097
Closed -$373K
DAWN
67
DELISTED
Day One Biopharmaceuticals
DAWN
-544,063
Closed -$5.07M
HOOD icon
68
PUT
Robinhood
HOOD
$85.2B
-1,656,000
Closed -$187M
LFCR icon
69
Lifecore Biomedical
LFCR
$162M
-71,040
Closed -$581K
LRMR icon
70
Larimar Therapeutics
LRMR
$416M
-45,218
Closed -$172K
LXEO icon
71
Lexeo Therapeutics
LXEO
$366M
-22,302
Closed -$221K
NEWP
72
New Pacific Metals
NEWP
$833M
-28,477
Closed -$100K
NVCR icon
73
NovoCure
NVCR
$2.04B
-10,723
Closed -$139K
NVDA icon
74
PUT
NVIDIA
NVDA
$5.01T
-11,000
Closed -$2.05M
OEF icon
75
PUT
iShares S&P 100 ETF
OEF
$19.8B
-19,600
Closed -$3.31M

Similar funds

Pale Fire Capital SE's Q1 2026 Portfolio in Review

As of Q1 2026, Pale Fire Capital SE held 81 positions worth $1.14B, down 24% from $1.49B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

Pale Fire Capital SE withdrew a net $182M in Q1 2026, closing 21 positions and reducing 8 holdings. Its most notable exit was Centerra Gold, an estimated $8.5M position sold in full.

By sector, the portfolio is most concentrated in Materials at 31% of assets, up from 16% a quarter earlier, followed by Communication Services and Consumer Staples.

Against the trend, Pale Fire Capital SE opened a new position in Phreesia worth $72.5M.

  • Pale Fire Capital SE's largest Q1 2026 buy was Phreesia: 8,649,329 shares worth $72.5M.
  • Pale Fire Capital SE added most to B2Gold in Q1 2026, an estimated $153M increase.
  • Pale Fire Capital SE's biggest Q1 2026 reduction was Galiano Gold, cutting an estimated $11.1M.
  • Pale Fire Capital SE fully exited Centerra Gold in Q1 2026, selling an estimated $8.5M.
  • Pale Fire Capital SE's ten largest holdings make up 85% of its $1.14B portfolio in Q1 2026.
  • Pale Fire Capital SE opened 21 new positions and closed 21 in Q1 2026.
  • Pale Fire Capital SE's portfolio value fell 24% quarter-over-quarter to $1.14B.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.